An assessment of the isoniazid preventive therapy programme for children in a busy primary healthcare clinic in Nelson Mandela Bay Health District, Eastern Cape Province, South Africa by Black, F et al.
217       March 2018, Vol. 108, No. 3
RESEARCH
Tuberculosis (TB) is a significant contributor to the international 
and national burden of disease. In 2015, there were an estimated 
10.4 million new cases of TB globally; South Africa (SA) ranked 
among the top six countries, accounting for 60% of the total number 
of new cases.[1] Although SA managed to curb its TB incidence to 
860/100 000 in 2013,[2] TB in the Nelson Mandela Bay Health District 
(NMBHD) remains rampant, with an incidence of 949.3/100 000.[3] It has 
consequently been identified as one of four TB crisis districts in the 
country.[4] The burden of childhood TB is substantial. The World 
Health Organization (WHO) estimates that childhood TB accounts 
for ~10% of the total number of TB cases worldwide, although in 
high-burden areas the incidence has been shown to be significantly 
higher.[2] In the past, childhood TB has been overlooked as a health 
priority. The focus of global public health campaigns to control TB 
has been to reduce transmission by early case-finding and treatment 
of highly infectious patients.[5] As children often have paucibacillary 
TB, their risk of transmission is low and, thus, they have largely gone 
unnoticed.
The burden of childhood TB can be greatly reduced by active contact 
tracing and diligent prescribing of chemoprophylaxis to patients in 
whom active TB has been excluded.[6] The rationale behind contact 
screening is twofold. Firstly, it provides TB preventive therapy to 
high-risk individuals, such as young children and HIV-infected 
individuals. Secondly, it actively traces contacts who have TB and 
treats them appropriately.[7] A 6 - 9-month course of isoniazid 
preventive therapy (IPT) can diminish the risk of developing TB 
disease by two-thirds; with good compliance this benefit may be 
increased to almost 90%.[8] The National Department of Health 
(NDoH) has developed TB control programme guidelines for the 
management of child contacts (Fig. 1). Since 2008, these guidelines 
have recommended a symptom-based screening approach that does 
not require a skin test or chest radiograph in an asymptomatic child, 
as recommended in earlier guidelines.[9] 
However, contact tracing, screening and IPT initiation have been 
poorly implemented in areas of SA[10-15] and other low- and middle-
income countries.[16-19] In Malawi, operational challenges such as high 
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Background. Tuberculosis (TB) is a significant contributor to the international and national burden of disease. Global estimates suggest 
that there were 10.4 million new cases of TB in 2015. Children accounted for ~10% of these cases, although in South Africa (SA) this figure 
is thought to be higher. Despite clear evidence that isoniazid preventive therapy (IPT) can reduce the risk of progression from TB infection 
to disease in TB contacts, IPT has been poorly implemented in SA national TB control programmes.
Objectives. To determine current practices regarding the identification and management of child contacts (<5 years of age) at a primary care 
clinic in the Nelson Mandela Bay Health District, Eastern Cape Province, SA. 
Methods. A cross-sectional descriptive study was conducted using a retrospective record review of infectious TB index patients aged 
≥15 years. Folders of index patients with bacteriologically confirmed pulmonary TB, who started TB treatment between 21 October 2011 and 28 Feb -
ruary 2014, were included. A sample size of 246 child contacts was required to obtain adequate power. A 95% confidence interval (CI) was 
used to determine statistically significant results. 
Results. Index patient records (N=491) were assessed and 261 child contacts identified. In a high percentage of index patient folders (87.5%; 
n=430), contacts were documented, although only 0.53 child contacts were identified per index patient. Of the 261 child contacts identified, 184 
(70.5%) were screened for TB, 2 started TB treatment and 108/184 (58.7%) started IPT. For the remaining 74 (40.2%) children, there was no 
documentation of further management. Only 4 (3.7%) children completed the 24-week IPT course. Male patients reported fewer child contacts 
(χ2 =7.31; p=0.01; odds ratio (OR) 0.6; 95% CI 0.42 - 0.86) and were less likely to bring contacts for screening (χ2=8.98; p=0.003; OR 0.41; 
95% CI 0.24 - 0.72). Retreatment index patients were also less likely to bring contacts for screening (χ2=6.37; p=0.01; OR 0.45; 95% CI 0.25 - 
0.81) and those who were screened were less likely to initiate IPT (χ2=4.05; p=0.04; OR 0.54; 95% CI 0.3 - 0.95). 
Conclusion. Despite contacts being well documented, child contacts were poorly identified. The fall-out of children at each step from 
identification to IPT completion was unacceptably high. Contacts of male patients and retreatment index patients were at greater risk of 
poor management. Recommendations to improve IPT delivery at national and local level include a review of the national IPT guidelines, 
considering the relative success of shorter courses of TB prophylaxis, the use of standardised IPT stationery, staff training and the 
involvement of community health workers in contact management.
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transport costs and delays in test results were 
found to impede IPT delivery,[17] while in an 
Indian study the lack of healthcare worker 
knowledge and awareness about IPT were 
reasons for poor IPT implementation.[16] 
Qualitative studies in Cape Town have shown 
that barriers to a successful IPT programme 
included health systems issues, such as staff 
shortages and patient- and community-
related factors, including poverty, stigma 
and parents’ resistance to treatment.[20] The 
successful implementation of child contact 
screening and management is hampered by 
a variety of challenges and barriers unique 
to each setting.[7] Information regarding IPT 
services in the Eastern Cape and NMBHD 
is lacking, with no baseline data. Identifying 
problem areas in child contact management 
within the TB programme may help to 
reduce childhood TB and ultimately assist in 
curbing the expanding TB epidemic. 
The hypothesis of this study was that  child 
contacts <5 years of age are not routinely 
identified, screened and administered IPT 
and that there is a large drop-out rate of 
children who start IPT.
The objectives of this study were to assess:
• whether child TB contacts are being 
identified, screened and managed according 
to the NDoH TB control programme 
guidelines at a single primary healthcare 
facility in NMBHD 
• the proportion of children who completed the 
required course of TB preventive medication 
• whether the age, gender, education and 
employment status of the index cases and 
their disease characteristics (HIV status, 
smear positivity and previous TB) relate to 
the documentation of child contacts, their 
screening and initiation of IPT. 
Methods
This cross-sectional descriptive study was con-
ducted at a primary healthcare clinic in the 
NMBHD, one of eight health districts in the 
Eastern Cape Province, SA. The district has a 
population of ~1.2 million, with children 
<5 years of age accounting for ~10%. In 
2012, the TB inci dence in NMBHD was 
reported as 949.3/100 000,[4] with 16% of cases 
in child ren ˂19 years of age and those aged 
<5 years accounting for 7.2% of the total 
case number.[3] The annual TB case load at the 
study site was ~300 (Ms B Ncanywa – personal 
communication, 2014). A retrospective record 
review using information collected by clinic staff 
during routine care of patients was conducted.
 Information regarding contacts should 
be routinely recorded at the back of each 
TB patient’s treatment card (name, surname, 
age, whether contacts were screened and if 
IPT or TB treatment was started). Eligible 
child contacts are screened. In those in 
whom active TB disease has been excluded, a 
6-month course of IPT should be given.[19,21,22] 
IPT is dispensed monthly and is recorded on 
a dedicated IPT card filed in the TB room. 
Adult index patients who started TB 
treat ment between 21 October 2011 and 
28 Feb ruary 2014 were included. As per the 
literature and in line with WHO standards, 
an adult TB patient was defined as being 
>15 years of age.[1,13,16,23] Child contacts 
were defined as children <5 years of age, 
who are in close contact with an adult with 
infectious TB.[21,22] Only index patients with 
bacteriologically confirmed pulmonary TB 
were enrolled. These are patients with smear 
and/or GeneXpert (Cepheid, USA) and/or 
culture-positive sputum results, including 
drug-sensitive and drug-resistant pulmonary 
TB disease. HIV status was not recorded on 
the IPT card; therefore, any child contact 
>5 years old, regardless of HIV status, was 
not included in the study. Completion of IPT 
treatment was defined as a contact having 
collected at least 24 weeks of IPT. If a contact 
was discharged after 6 months of treatment, 
but had not collected medication for the 
relevant time period, they were not classified 
as having completed treatment. 
A similar study in a high-TB-burden setting 
established that 20% of eligible child contacts 
were initiated on IPT.[13] This figure was 
used to calculate the sample size of 246 child 
contacts, which was required to obtain a 95% 
Observe for symptoms
Evaluate/refer if symptoms indicative of TB
Documented TB exposure 
Close contact with an adult or adolescent with pulmonary TB or 
child with smear-positive TB 
Close contact is dened as any household contact or contact 
outside the household that is of sucient duration and proximity 
to pose a high risk of infection
Are there any current symptoms or signs suspicious of TB, such as 
cough, wheeze, fever, lethargy, fatigue, weight loss or visible mass 
in the neck? 
No current symptoms or signs Symptoms or signs present
Investigate for TB
Not TB TB diagnosed
Follow-up in 1 - 2 weeks
Treat for TB 
Enter into 
TB register
Child well
Persistent non-remitting 
symptoms
≥5 years or
 HIV-uninfected
<5 years or 
HIV-infected Consider treating for TB 
or refer to hospital
No preventive 
therapyINH for 6 months
Fig. 1. Flow diagram for screening a child with documented tuberculosis exposure. (TB = tuberculosis; 
INH = isoniazid.)[21]
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confidence interval (CI) with a 5% precision, 
using EpiCalc 2000 (Microsoft, USA).[24] 
Index patients were identified from the 
drug-sensitive TB treatment register and 
folders in the TB filing system at the clinic. 
Folders of all eligible index patients who 
started TB treatment at the clinic from 
21 Octo ber 2011 to 28 February 2014 
were reviewed, together with all IPT cards 
for children who started therapy during 
this period. An attempt was made to link 
these contacts to an index case. Both drug-
sensitive and drug-resistant index patients 
were enrolled. In line with NDoH and WHO 
guidelines, contacts of multidrug-resistant 
TB are not administered second-line TB 
drugs for prophylaxis.[21,22,25] According to 
local practice, these contacts are managed 
at primary clinic level in the same way as 
contacts of drug-sensitive patients (Sr N Ges-
wint – personal communication, 2014).
An adapted data collection tool based on 
that of Osman et al.[15] was used to record 
information relating to the identification of 
child contacts, the index patient demographics 
and disease characteristics, as well as the 
clinical management of contacts receiving 
IPT. Data were entered into Microsoft 
Excel 2010 (Microsoft, USA) and analysed 
using statistical programme R (R Foundation 
for Statistical Computing, Austria).[26] 
Ethical approval
In accordance with the principles of good 
clinical practice, permission to conduct the 
study was obtained from the Human Research 
Ethics Committee of the University of Cape 
Town (ref. no. HREC REF 345/2014). Approval 
was also obtained from the Eastern Cape 
Health Department and the NMBHD TB 
directo rate to conduct research in the area.
Results
From 21 October 2011 to 28 February 2014, 
690 patients were recorded in the TB register 
at the clinic. These included children and 
adults with pulmonary and extrapulmonary 
disease. Folders of 491 index patients who 
met the inclusion criteria were in the filing 
system and reviewed. A total of 261 child 
contacts were identified from 474 drug-
sensitive and 17 drug-resistant index cases. 
More than half of the index patients were 
men (54%) and the index patients’ mean 
(standard deviation (SD)) age was 36.6 
(13.4) years. Unemployment rates in the area 
were high, with 56% of index patients not 
working. Almost 97% of index patients were 
tested for HIV; 78% were negative.
Of the 491 index patient folders, 61 
(12.5%) had no documentation relating to 
contacts of any age, and 261 child contacts 
were identified (Fig. 2). Six were excluded 
from the analysis owing to no age being 
recorded – only the word ‘child’. The mean 
number of contacts of any age identified 
was 3.6 (2.9) and a mean of 0.53 (0.8) child 
contacts were identified per index patient. 
The mean age of child contacts was 2.25 
(1.3) years (range 1 month - 5 years).
Of the 261 child contacts identified, 70.5% 
(n=184) were screened for TB using one 
or more of the following: symptom screen, 
tuberculin skin test (TST), chest radiograph, 
gastric washing or sputum and referral for 
further management. The most common 
methods of screening included a symptom 
screen (n=111; 60.3%) and/or a TST (n=145; 
78.7%). Of those who had a TST, almost 
half (47.6%) did not have a documented 
symptom screen prior to the TST being 
done, as is recommended in the NDoH 
guidelines.[21,22]
Only 2 (1%) of the 184 patients screened 
were known to have started treatment for 
TB disease, although in many cases (n=74; 
40.2%) there was no documentation of 
whether TB treatment or IPT was initiated. 
Of the initial 255 contacts, 56.8% (n=145) 
had no documentation of initiation of any 
therapy – preventive or other. One hundred 
and eight (58.7%; CI ±7.11) contacts were 
documented on the index case folder as 
having started TB preventive therapy, but 
only 74 (68.5%) IPT cards were found for 
patients who commenced IPT treatment 
during this period.
On 7 IPT cards, the index patient’s name 
was not recorded. There were such cards 
for 9 contacts who were not eligible for IPT, 
either owing to the contact’s age (3 were 
>5 years) or to the disease characteristics 
of the index patient (there were 6 cards for 
contacts of index patients who had sputum-
negative or extrapulmonary TB). These 
contacts were excluded from the analysis.
The majority (91.8%) of child contacts 
who started TB preventive therapy were 
given isoniazid (INH). The drugs used for 
the remaining 8% were not documented. 
There was documentation of side-effects, 
routine symptom screens and weight checks 
on only 1 IPT card.
 The median (interquartile range (IQR)) 
number of weeks of IPT collection was 8 
(11.25). Of those who started IPT, 10 child ren 
were reported to have completed 6 months 
Index patients enrolled (n=491)
Child contacts documented (n=261)
(child contacts per index patient (n=0.53))
Screened 
(n=184) (70.5% of child
 contacts identied)
Contacts started on IPT according 
to index patient folder (n=108)
 (58.7% of contacts screened)
Contacts started on TB 
treatment (n=2)
 (1% of contacts screened)
No documentation of IPT or TB 
treatment initiated in index 
patient folder (n=74) 
(40.2% of contacts screened)
 IPT cards (n=74) (68.5% of contacts 
started on IPT according to index 
patient folders)
Contacts who completed 
treatment (≥24 weeks) (n=4) 
(3.7% of total initiated on IPT) 
 Contacts who completed 6 months' IPT (n=10) 
(9.3% of total initiated on IPT),
 but who did not complete 24 weeks (mean 18.5 weeks) 
No documentation of further 
management (n=71)
(29.5% of contacts identied)
Contacts excluded owing to 
ages not specied (n=6)
Fig. 2. Flow diagram of child contacts, from identification to treatment completion. (TB = tuberculosis; 
IPT = isoniazid preventive therapy.)
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of treatment, but they had not received IPT for varying lengths of 
time during this period; therefore, the actual number of weeks of IPT 
appeared shorter (mean 18.5 (2.83)). Only 4 children (3.7%; CI 
±3.56) completed the 24-week course. Fig. 3 depicts this decay from 
identification to IPT completion.
χ2 tests were used to establish the relationship between the 
index patient’s demographics (age, gender, employment status), their 
disease characteristics (HIV status, smear positivity and previous TB) 
and the identification and management of child contacts. Tables 1 - 3 
show the results of these analyses. Of statistical significance is that 
documentation of child contacts for male index patients (p=0.01) 
was less likely. Male patients (p=0.003) and those who were retreated 
for TB (p=0.01) were less likely to bring their contacts for screening. 
Child contacts of index patients retreated for TB were less likely to 
initiate IPT (p=0.04).
Discussion
Contact identification was well reported in index patient folders. 
Only 12.5% of patient folders had no documentation of contacts. 
However, the number of child contacts per index patient (mean 0.53 
(0.8)) was lower than that in previous studies (0.7 - 1.3 child contacts 
per infectious TB case).[11-15] The study site relies on passive contact 
tracing, i.e. index patients are requested to bring their contacts to 
the clinic for screening; they are not actively traced by a healthcare 
worker. Although active contact tracing has been shown to yield 
substantially more TB cases,[17] it is only the first of many steps, 
including appropriate management of infectious patients, as well 
as diligent supervision of child contacts, required to prevent TB in 
children. The screening process, IPT initiation and follow-up in 
children are considerable hurdles in TB preventive programmes.[15]
Of the 255 contacts included in the analysis, 72% (n=184) were 
screened for active TB disease. Although this is higher than that 
found in a previous study (42%),[15] the opportunity to screen 
young children was missed in more than a quarter of child contacts 
identified. This could relate to the problem of passive case finding. 
The majority of children (79%) were screened using a TST. Of those 
thus screened, for almost half (48%) there was no documentation of 
a symptom screen. This practice does not follow the NDoH TB 
control programme screening protocol in either the 2009 or 2013 
guidelines.[21,22] These guidelines state that investigations should be 
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Fig. 3. Fall-out of child contacts, from identification to treatment completion. 
(IPT = isoniazid preventive therapy.)
Table 1. Relationship between index patient demographic factors and disease characteristics and child contacts <5 years of age
Demographic factors Records analysed, n
Records with child contacts
<5 years of age, n (%) χ2 Odds ratio(95% CI) p-value
Gender* (n=490)
Male 264 100 (37.9) 7.31 0.60 (0.42 - 0.86) 0.01
Female 226 114 (50.4)
Age, years* (n=490)
≤35 247 117 (47.4) 2.47 1.35 (0.95 - 1.94) 0.12
>35 243 97 (39.9)
Employment status† 
(n=437)
Employed 163 79 (48.5) 1.49 1.30 (0.88 - 1.92) 0.22
Unemployed 274 115 (42.0)
HIV status‡ (n=475)
Infected 93 40 (43.0) 0.00 0.96 (0.61 - 1.52) 0.96
Uninfected 382 168 (44.0)
Previous TB‡ (n=483)
Yes 137 67 (48.9) 1.83 1.34 (0.9 - 2.0) 0.18
No 346 144 (41.6)
Smear status§ (n=478)
Positive 383 176 (45.9) 2.78 1.52 (0.96 - 2.43) 0.095
Negative 95 34 (35.8)
CI = confidence interval.
*n=490 (not n=491) due to missing data required for analysis.
†Excluding pensioners, students and ‘unknown’.
‡Excluding ‘unknown’.
§Excluding ‘not done’ and ‘not documented’.
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performed only if a symptom screen is positive. There is little value 
in performing a TST in a recently exposed, asymptomatic child, 
given that the delayed-type hypersensitivity may take up to 3 months 
to develop.[27] Children who are exposed to an infectious adult with 
TB and are asymptomatic, require IPT regardless of the TST result. 
A TST is of greater value when attempting to confirm a diagnosis 
of TB disease in a sick child, although even then it can be falsely 
negative in a subgroup of patients who have severe disease or are 
immunocompromised.[27]
The ‘no test’ screening method has been shown to be the most cost-
effective technique in young children exposed to TB.[28] Unavailability 
of tuberculin, lack of staff expertise to interpret test results, additional 
transport costs, time required to complete the screening process and 
increased staff workload have all been described as barriers to IPT 
Table 2. Relationship between index patient demographic factors and disease characteristics and child contacts <5 years of age screened
Demographic factors Records analysed, n
Records with documentation of 
contact screening, n (%) χ2 Odds ratio (95% CI) p-value
Gender* (n=255)
Male 104 64 (61.5)
8.98 0.41 (0.24 - 0.72) 0.003
Female 151 120 (79.5)
Age, years* (n=255)
≤35 160 118 (73.7)
0.35 1.23 (0.7 - 2.16) 0.55
>35 95 66 (69.4)
Employment status† (n=232)
Employed 91 67 (73.6)
0.09 1.14 (0.63 - 2.07) 0.77
Unemployed 141 100 (70.9)
HIV status‡ (n=246)
Infected 50 36 (72.0)
0.00 1.02 (0.52 - 2.05) 1.00
Uninfected 196 140 (71.5)
Previous TB‡ (n=251) 
Yes 73 44 (60.2)
6.37 0.45 (0.25 - 0.81) 0.01
No 178 137 (76.9)
Smear status§ (n=249)
Positive 208 152 (73.0)
0.56 1.40 (0.69 - 2.88) 0.45
Negative 41 27 (65.8)
CI = confidence interval.
*n=255 (not n=261) due to missing data required in analysis.
†Excluding pensioners, students and ‘unknown’.
‡Excluding ‘unknown’.
§Excluding ‘not done’ and ‘not documented’.
Table 3. Relationship between index patient demographic factors and disease characteristics and child contacts <5 years of age initiated 
on IPT 
Demographic factors Records analysed, n
Records with documenta-
tion of IPT initiated, n (%) χ2 Odds ratio (95% CI) p-value
Gender* (n=253)
Male 104 42 (40.4) 0.24 0.85 (0.51- 1.42) 0.62
Female 149 66 (44.3)
Age, years* (n=253)
≤35 159 71 (44.6) 0.48 1.24 (0.74 - 2.09) 0.49
>35 94 37 (39.4)
Employment status† (n=230)
Employed 91 46 (50.5) 3.36 1.71 (1.0 - 2.92) 0.07
Unemployed 139 52 (37.4)
HIV status‡ (n=244)
Infected 50 21 (42) 0.0 0.99 (0.53 - 1.86) 1.0
Uninfected 194 82 (42.2)
Previous TB‡ (n=249)
Yes 73 24 (32.8) 4.05 0.54 (0.3 - 0.95) 0.04
No 176 84 (47.7)
Smear status§ (n=247)
Positive 206 90 (43.7) 0.46 1.34 (0.67 - 2.69) 0.50
Negative 41 15 (36.6)
IPT = isoniazid preventive therapy; CI = confidence interval.
*n=253 (not n=261) due to missing data required for the analysis.
†Employment status excluding pensioners, students and ‘unknown’.
‡Excluding ‘unknown’.
§Excluding ‘not done’and ‘not documented’.
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delivery.[29] The lack of a TST and chest radiography should not be a 
barrier to child contact screening and management.[25,30]
Of the 184 children who were screened, 59% (n=108) were docu-
mented as having started IPT, 2 started full TB treatment and for 
40% (n=74) there was no documentation of further management or 
follow-up. The last represents missed opportunities for providing TB 
preventive therapy in a community where TB is rife. Due to the lack 
of documentation in patient folders, it was not possible to determine 
whether the caregivers of these children were offered IPT and declined, 
or whether IPT was never prescribed. Caregivers’ perception that a 
child who is well does not need medication, interfered with IPT 
provision in previous studies.[11,18,19] This perception, compounded 
by the system of passive contact tracing, could have a significant 
negative effect on IPT provision in this setting. The fall-out of child 
contacts could also relate to the screening methods used. In this 
low-income setting, patients may be unable to afford to return for 
TST results and chest radiographs, with consequent loss of follow-
up. Additional barriers to initiation of and adherence to IPT include 
stigma related to TB, community misconceptions around the role 
of IPT and social problems, such as substance abuse and domestic 
violence.[20] 
There were 74 IPT cards for children starting IPT during the 
study period, which represents 69% of those who started preventive 
therapy and 40% of the total number who were screened. There were 
9 IPT cards for 9 children who started IPT, who were either >5 years 
of age or who were contacts of non-bacteriologically confirmed 
pulmonary or extrapulmonary TB index patients. This showed a 
deviation from the NDoH TB control programme protocol, which 
states that only contacts of index patients with bacteriologically 
confirmed pulmonary TB who are <5 years of age are eligible for IPT. 
Children >5 years of age are eligible if they are HIV-infected.[21,22] 
There was no documentation of the HIV status for children >5 years 
of age, as mentioned above. Also, there were 7 cards with poor or no 
documentation of the index patient’s name, precluding assessment of 
these contacts.
The number of IPT cards found may be an under-representation 
of the actual number of existing cards. Firstly, the filing system was 
inefficient and not user friendly, mostly owing to a lack of accessible 
filing space in the clinic. Secondly, it was sometimes difficult to link 
the IPT card and the index patient.
The IPT card system attempted to formalise the provision of 
IPT in the district. The WHO, however, recommends the use of a 
dedicated IPT register in which to document household contacts 
details.[25] The positive effects of such a system were demonstrated 
by studies in India[31] and Cape Town,[32] with more contacts being 
identified and initiated on IPT, better documentation of information 
and improved adherence rates. A register may resolve the problems 
experienced with the disorganised IPT card filing system, allowing 
easier monitoring of the programme. 
Improvements could be made to the system. The index patient 
register number and sputum drug sensitivities should also be 
documented on the IPT card to link the contact and index case 
and adjust management accordingly. For example, the NDoH TB 
control programme guidelines recommend a 4-month rifampicin 
course instead of a 6-month INH course as preventive therapy in 
INH-resistant index patients.[22] Furthermore, the HIV status of the 
contact should be recorded. HIV-infected children are at extremely 
high risk of developing TB disease,[33] and all HIV-infected children, 
regardless of age, should be administered IPT after exposure to a 
known bacteriologically confirmed pulmonary TB case.[22]
There was no routine documentation of symptom checks or repeat 
weight checks at subsequent visits to collect IPT. The importance 
of this is twofold. Firstly, to detect TB disease in children,[22,32] and, 
secondly, to increase the dose of INH according to the increasing 
weight of the child to maintain an effective dose throughout 
treatment. Side-effects of IPT were never documented on the 
audited IPT cards. Although side-effects from INH are uncommon, 
addressing even minor ones and re-assuring caregivers may improve 
retention of contacts receiving IPT.[34]
The WHO and NDoH recommend a 6-month course of INH 
to prevent TB in child contacts;[22,25] however, adherence rates are 
poor with this regimen.[10,11,15] Contacts in this study collected IPT 
for a median (IQR) number of 8 (11.25) weeks. Only 4 (3.7%) 
contacts completed the course. Some contacts completed 6 months 
of treatment during the relevant time, but had collected INH for 
˂24 weeks. These missed doses may have been the result of poor 
patient compliance or because of INH stock-outs (Sr N Geswint – 
personal communication, 2014). Compliance with shorter courses of 
TB preventive therapy, i.e. 3- or 4-month courses of INH/rifampicin 
or rifampicin alone, is significantly better[10,35,36] and should be 
considered in SA. 
Results indicated that child contacts of male index patients and 
index patients with a previous history of TB are at high risk of poor 
management. Osman et al.[15] demonstrated similar results in Cape 
Town. In general, male TB patients have been shown to delay seeking 
medical attention and are more likely to default their treatment than 
female TB patients.[37] This type of health-seeking behaviour could 
negatively impact the care of child contacts. These index patients 
should be earmarked for more attentive consultations and in-depth 
counselling regarding their disease and the risk it poses to their 
contacts.
Study limitations
This study has a number of important limitations. It relied on data 
collected from patient files. As with all record reviews, a major 
limitation is missing information.[38] The study only took into account 
patients who started TB treatment. It did not account for patients 
who were diagnosed with TB, but defaulted treatment initiation, or 
those who defaulted after transfer from a hospital. Therefore, the 
number of child contacts initiated on IPT is an under-representation 
of the number of child contacts who should have received IPT. The 
study design did not allow for the assessment of the uptake of IPT 
by caregivers. Caregivers’ refusal to medicate has been shown to be a 
significant barrier to providing children with IPT.[20] 
Conclusion
The appropriate management of child TB contacts is essential to 
reduce the burden of disease in children. The results of this study 
demonstrate inadequate child contact tracing and significant fall-out 
of children at various time points in the contact screening-treatment 
continuum. The findings emphasise that documentation is poor, and 
that deviation from protocols is common. Operational challenges 
such as a suboptimal recording tool and a disorganised filing system 
contribute to these outcomes. Staff- and patient-related factors may, 
however, also play a role. Although this study was conducted at a 
single site, the problem of poor contact management is likely to be 
pervasive throughout other areas in the district.
The improvement of TB contact tracing and management requires 
consolidated buy-in and increased commitment from all stakeholders, 
including the community. Recommendations for the NDoH include a 
review of the national IPT guidelines, taking into account the relative 
success of shorter courses of TB prophylaxis. The use of standardised 
IPT stationery, including a register and patient appointment cards, 
could improve filing and follow-up systems. Information with regard 
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to the HIV status of the child, the index patient register number and 
drug sensitivities should be included in the register. Provincial and 
district level recommendations pertain to the inclusion of indicators 
related to child IPT in the quarterly reports requested by the NDoH. 
Regular staff training and evaluation, adequate support and active 
involvement of community health workers in contact tracing and 
monitoring may improve outcomes. Further research is required in 
the management of child contacts of drug-resistant TB patients, as 
well as the qualitative aspects of barriers or perceived barriers relating 
to patient, healthcare worker and operational challenges that hinder 
the delivery of IPT to children in this setting. 
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